Cascade genetic counseling and testing in hereditary syndromes: inherited cardiovascular disease as a model: a narrative review
- PMID: 38184510
- PMCID: PMC11153290
- DOI: 10.1007/s10689-023-00356-x
Cascade genetic counseling and testing in hereditary syndromes: inherited cardiovascular disease as a model: a narrative review
Abstract
Inherited cardiovascular diseases cover the inherited cardiovascular disease familial hypercholesterolemia and inherited cardiac diseases, like inherited cardiomyopathies and inherited arrhythmia syndromes. Cascade genetic counseling and testing in inherited cardiovascular diseases have had three decades of academic attention. Inherited cardiovascular diseases affect around 1-2% of the population worldwide and cascade genetic counseling and testing are considered valuable since preventive measures and/or treatments are available. Cascade genetic counseling via a family-mediated approach leads to an uptake of genetic counseling and testing among at-risk relatives of around 40% one year after identification of the causal variant in the proband, with uptake remaining far from complete on the long-term. These findings align with uptake rates among relatives at-risk for other late onset medically actionable hereditary diseases, like hereditary cancer syndromes. Previous interventions to increase uptake have focused on optimizing the process of informing relatives through the proband and on contacting relatives directly. However, despite successful information dissemination to at-risk relatives, these approaches had little or no effect on uptake. The limited research into the barriers that impede at-risk relatives from seeking counseling has revealed knowledge, attitudinal, social and practical barriers but it remains unknown how these factors contribute to the decision-making process for seeking counseling in at-risk relatives. A significant effect on uptake of genetic testing has only been reached in the setting of familial hypercholesterolemia, where active information provision was accompanied by a reduction of health-system-related barriers. We propose that more research is needed on barriers -including health-system-related barriers- and how they hinder counseling and testing in at-risk relatives, so that uptake can be optimized by (adjusted) interventions.
Keywords: Cascade genetic testing; Familial hypercholesterolemia; Family communication; Genetic counseling; Hereditary cancer syndromes; Inherited cardiovascular diseases.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Similar articles
-
Long-Term Follow-Up Study on the Uptake of Genetic Counseling and Predictive DNA Testing in Inherited Cardiac Conditions.Circ Genom Precis Med. 2020 Oct;13(5):524-530. doi: 10.1161/CIRCGEN.119.002803. Epub 2020 Aug 14. Circ Genom Precis Med. 2020. PMID: 33079600 Free PMC article.
-
Cascade genetic testing for hereditary cancer syndromes: a review of barriers and breakthroughs.Fam Cancer. 2024 Jun;23(2):111-120. doi: 10.1007/s10689-024-00373-4. Epub 2024 Mar 26. Fam Cancer. 2024. PMID: 38530571 Review.
-
Outcomes from a pilot genetic counseling intervention using motivational interviewing and the extended parallel process model to increase cascade cholesterol screening.J Genet Couns. 2022 Feb;31(1):164-175. doi: 10.1002/jgc4.1466. Epub 2021 Jul 14. J Genet Couns. 2022. PMID: 34260792
-
A clinically structured and partnered approach to genetic testing in Trinidadian women with breast cancer and their families.Breast Cancer Res Treat. 2019 Apr;174(2):469-477. doi: 10.1007/s10549-018-5045-y. Epub 2018 Dec 4. Breast Cancer Res Treat. 2019. PMID: 30515680
-
How to inform relatives at risk of hereditary diseases? A mixed-methods systematic review on patient attitudes.J Genet Couns. 2019 Oct;28(5):1042-1058. doi: 10.1002/jgc4.1143. Epub 2019 Jun 19. J Genet Couns. 2019. PMID: 31216099
Cited by
-
Facilitators and Barriers to Uptake of Genetic and Cascade Testing in Familial Hypercholesterolemia: a Systematic Review.Int J Behav Med. 2025 Apr 8. doi: 10.1007/s12529-025-10357-y. Online ahead of print. Int J Behav Med. 2025. PMID: 40199835
-
Mismatch in testing: a retrospective analysis of mismatch repair testing in endometrial cancer and Lynch syndrome diagnosis in multiple specialist centres in the UK and Ireland (March 2022-March 2023).BMJ Oncol. 2025 Jun 9;4(1):e000688. doi: 10.1136/bmjonc-2024-000688. eCollection 2025. BMJ Oncol. 2025. PMID: 40510444 Free PMC article.
References
-
- Ingles J, McGaughran J, Scuffham P, Atherton J, Semsarian C (2012) A cost-effectiveness model of genetic testing for the evaluation of families with hypertrophic cardiomyopathy. Heart. ;98:625–30. https://doi.org/0.1136/heartjnl-2011-300368 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical